NCT05186649View on ClinicalTrials.gov

Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis

UnknownOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

July 15, 2022

Conditions
Left Atrial Appendage AneurysmMitral Stenosis
Interventions
OTHER

WARFARIN

5 mg of daily dosage

Trial Locations (1)

78500

RECRUITING

Karachi Institute of Heart Disease, Karachi

Sponsors
All Listed Sponsors
collaborator

Advanced Education & Research Center

OTHER

collaborator

Karachi Institute of Heart Diseases

NETWORK

lead

University of Karachi

OTHER

NCT05186649 - Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis | Biotech Hunter | Biotech Hunter